Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma
- 1 August 2003
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 3 (8) , 1169-1176
- https://doi.org/10.1016/s1567-5769(03)00012-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Nucleoside Analogues for Chronic Hepatitis B: Antiviral Efficacy and Viral ResistanceAmerican Journal of Gastroenterology, 2002
- Epidemiology, Risk Factors, and Natural History of Hepatocellular CarcinomaAnnals of the New York Academy of Sciences, 2002
- Recent progress and new trends in the treatment of hepatitis BJournal of Medical Virology, 2002
- Management of patients with chronic hepatitis BJournal of Gastroenterology and Hepatology, 2002
- Treatment of chronic hepatitis BThe Lancet Infectious Diseases, 2001
- Interleukin-12 in the treatment of chronic hepatitis B and CAntiviral Research, 2001
- Lamivudine Treatment Can Overcome Cytotoxic T–Cell Hyporesponsiveness in Chronic Hepatitis B: New Perspectives for Immune TherapyHepatology, 2001
- Chronic hepatitis B: new therapies on the horizon?The Lancet, 1999
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993